Literature DB >> 8315388

The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A.

J L Hillson1, N S Karr, I R Oppliger, M Mannik, E H Sasso.   

Abstract

The ability of human VH3 immunoglobulins (Ig) to bind to staphylococcal protein A (SPA) via their Fab region is analogous to the binding of bacterial superantigens to T cell receptors. The present report establishes the structural basis for the interaction of SPA and VH3 Ig. We have studied a panel of 27 human monoclonal IgM that were derived from fetal B lymphocytes. As such, these IgM were expected to be encoded by unmutated germline genes. Binding to SPA in ELISA occurred with 15 of 15 VH3 IgM, but none of 12 IgM from the VH1, VH4, VH5, or VH6 families. The VH sequences of the 27 IgM were derived from 20 distinct VH elements, including 11 from the VH3 family. Use of D, JH, and CL genes was similar among VH3 and non-VH3 IgM. A comparison of the corresponding VH protein sequences, and those of previously studied IgM, identified a probable site for SPA binding that includes VH3 residues in framework region 3 (FR3), and perhaps FR1 and 3' complementary determining region 2. The results thus demonstrate that among human IgM, specificity for SPA is encoded by at least 11 different VH3 germline genes. Furthermore, like the T cell superantigens, SPA likely binds to residues in the VH framework region, outside the classical antigen-binding site of the hypervariable loops.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315388      PMCID: PMC2191074          DOI: 10.1084/jem.178.1.331

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Identification of the region of T cell receptor beta chain that interacts with the self-superantigen MIs-1a.

Authors:  A M Pullen; T Wade; P Marrack; J W Kappler
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

2.  Variable region sequences of five human immunoglobulin heavy chains of the VH3 subgroup: definitive identification of four heavy chain hypervariable regions.

Authors:  J D Capra; J M Kehoe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

3.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Complete amino acid sequence of the variable domains of two human IgM anti-gamma globulins (Lay/Pom) with shared idiotypic specificities.

Authors:  J D Capra; D G Klapper
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  Staphylococcal protein A binding to the Fab fragments of mouse monoclonal antibodies.

Authors:  W W Young; Y Tamura; D M Wolock; J W Fox
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

Review 6.  Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.

Authors:  J J Langone
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

7.  Further characterization of the alternative protein-A interaction of immunoglobulins: demonstration of an Fc-binding fragment of protein A expressing the alternative reactivity.

Authors:  M Inganäs; S G Johansson; J Sjöquist
Journal:  Scand J Immunol       Date:  1981-10       Impact factor: 3.487

8.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

Authors:  J Deisenhofer
Journal:  Biochemistry       Date:  1981-04-28       Impact factor: 3.162

9.  Human monoclonal rheumatoid factors derived from the polyclonal repertoire of rheumatoid synovial tissue: incidence of cross-reactive idiotopes and expression of VH and V kappa subgroups.

Authors:  K M Thompson; I Randen; J B Natvig; R A Mageed; R Jefferis; D A Carson; H Tighe; O Forre
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  33 in total

1.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity.

Authors:  M Graille; E A Stura; A L Corper; B J Sutton; M J Taussig; J B Charbonnier; G J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Superantigens and autoantigens may be involved in the pathogenesis of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  T Hashimoto; M Takishita; M Kosaka; T Sano; T Matsumoto
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 3.  Regulation and chance in the ontogeny of B and T cell antigen receptor repertoires.

Authors:  Michael Zemlin; Robert L Schelonka; Karl Bauer; Harry W Schroeder
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.

Authors:  Muriel Viau; Nancy S Longo; Peter E Lipsky; Lars Björck; Moncef Zouali
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 5.  B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

6.  Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins.

Authors:  Elisa Ventura; Francesca Sassi; Sara Fossati; Arianna Parodi; William Blalock; Enrica Balza; Patrizia Castellani; Laura Borsi; Barbara Carnemolla; Luciano Zardi
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

7.  Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E.

Authors:  A Genovese; J P Bouvet; G Florio; B Lamparter-Schummert; L Björck; G Marone
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

8.  Improved Protein-A separation of V(H)3 Fab from Fc after papain digestion of antibodies.

Authors:  Therese A Seldon; Karen E Hughes; David J Munster; David Y Chin; Martina L Jones
Journal:  J Biomol Tech       Date:  2011-07

Review 9.  From natural polyreactive autoantibodies to à la carte monoreactive antibodies to infectious agents: is it a small world after all?

Authors:  J P Bouvet; G Dighiero
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 10.  Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.

Authors:  Michele Dal-Bo; Francesco Bertoni; Francesco Forconi; Antonella Zucchetto; Riccardo Bomben; Roberto Marasca; Silvia Deaglio; Luca Laurenti; Dimitar G Efremov; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  J Transl Med       Date:  2009-08-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.